Innate Pharma S.A. (IPH.PA) - Stock Prices, Stock Peers & Analysis

Home
IPH.PA

Company Name	Innate Pharma S.A.
Symbol	IPH.PA
Currency	EUR
Price	1.61
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	130,327,608
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.59 - 2.8
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Mondher Mahjoubi M.D.
Website	https://www.innate-pharma.com

An error occurred while fetching data.

About Innate Pharma S.A.

Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well